The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,680.00
Bid: 6,420.00
Ask: 6,700.00
Change: 50.00 (0.75%)
Spread: 280.00 (4.361%)
Open: 6,320.00
High: 6,700.00
Low: 6,320.00
Prev. Close: 6,630.00
GDWN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

18 Dec 2017 11:00

RNS Number : 6363Z
Goodwin PLC
18 December 2017
 

GOODWIN PLC

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

for the half year ended 31st October 2017

 

CHAIRMAN'S STATEMENT

 

I am pleased to report that the pre-tax profit for the Group for the first six month period ending 31st October 2017 was £6.10 million (2016 : £6.05 million), an increase of 1% from a revenue of £61.89 million.

The current workload as at 31st October 2017 stands at £84 million, unchanged from 12 months ago. The order input for the first six months of this financial year is the same as for the same period last financial year. Due to the persistent low activity in the oil, gas and mining industries which is now into its third year, the Group had no alternative than to further reduce the labour force by 50 since April 2017 and the total number of Group employees now stands at 1,070.

Due to the further improvement on the refractory engineering side of our business, we expect to see the Group profitability for the second half of the year starting to move forward again especially as compared to the Group figures for the six months to 30th April 2017.

The pre-tax profit for the first half of this financial year benefitted from a gain of £1.61 million that was realised when Gold Star Powders India sold its one acre of land and factory facility it purchased in 2003 for £110,000. Gold Star Powders has now moved to the same site as Goodwin Pumps India and currently rents its building from Goodwin Pumps India who purchased three acres of land in 2005 for £325,000.

Considerable effort and focus on cash flow improvement is being made and, whilst the cash flow position at the half year is largely unchanged as compared to 30th April 2017, we expect to see a significant improvement by 30th April 2018.

Although the oil price is now just over US Dollar 60 per barrel and the iron ore price is similarly just over US Dollar 60 per tonne, there is little reason to expect an upturn in the release of orders for new capacity in these capital equipment needy markets until 2020. We are, however, not relying on an immediate upturn in these industries and have been focusing on trying to win business in nuclear recycling and decommissioning and processing of mining industry waste materials where our potential customers are receiving closer scrutiny by environmental agencies.

An example of success here is the receipt in the first half of this financial year of a US Dollar 7.3 million order for large machined and fabricated stainless steel castings for the nuclear fuel decommissioning industry in the USA.

 

J. W. Goodwin

Chairman

18th December 2017

 

 

Management report

 

Financial Highlights

 

 

Unaudited Half Year to

Unaudited Half Year to

Audited Year Ended

 

31st October

31st October

30th April

 

2017

2016

2017

 

£'m

£'m

£'m

Consolidated Results

 

 

 

Revenue

61.9

69.9

131.6

Operating profit

6.4

6.5

9.9

Profit before tax

6.1

6.0

9.2

Profit after tax

4.4

4.2

6.8

Capital Expenditure

4.0

3.2

7.6

Earnings per share (Basic and Diluted)

58.38p

54.53p

84.47p

Turnover

Sales revenue of £61,893,000 for the half year represents an 11.4% decrease from the £69,889,000 achieved during the same period last year.

Profit Before Tax

Profit before tax for the six months of £6,108,000 is up 1.0% from the £6,047,000 achieved for the same six month period last year.

Risks and Uncertainties

The Group, mainly through its centralised management structure, makes best endeavours to have in place internal control procedures to identify and manage the key risks and uncertainties affecting the Group. We would refer you to page 8 of the Group Annual Accounts to 30th April 2017 which describes the principal risks and uncertainties, and to note 20 (page 52) which describes in detail the key financial risks and uncertainties affecting the business such as credit risk and foreign exchange risk.

Judging the future relationship of the major currency pairs of the US Dollar, Sterling and the Euro continues to be a challenge.

Report on Expected Developments

This report describes the expected developments of the Group during the year ended 30th April 2018. The report may contain forward-looking statements and information based on current expectations, and assumptions and forecasts made by the Group. These expectations and assumptions are subject to various known and unknown risks, uncertainties and other factors, which could lead to substantial differences between the actual future results, financial performance and the estimates and historical results given in this report.

Many of these factors are outside the Group's control. The Group accepts no liability to publicly revise or update these forward-looking statements or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

2018/19 Outlook

Despite the continued shortage of work within our foundry, where we have been taking the opportunity of enhancing our facility and capacity in this quiet period of activity, we expect the Group overall to start showing improved profitability and cash flow by the financial year end 30th April 2018.

This improvement is a feature of a continued expansion of activity and profitability in the refractory engineering part of the Group especially in our eight companies that supply consumables to the jewellery casting industry which, in line with the world economy overall, is in a period of revival. The performance of these refractory companies has also been enhanced by the demise of our major world competitor based in the USA, who was the world leader 20 years ago. In September 2017 they finally closed their doors, which has resulted in a substantial surge in order input for our price-competitive, consistent products that we have developed a global reputation for supplying.

As mentioned in the year end accounts to 30th April 2017, excellent progress is being made in India where there is significant growth in the overall economy and our submersible pump company and jewellery investment powder company are expected to achieve record trading results for the year ending 30th April 2018. The results in our Indian submersible pump company are also benefitting from sales orders arriving from our newly formed pump company in South Africa, which we are pleased to report will make respectable profits and sales in its first full year of trading

Going concern

The Group cash flow has deteriorated by a modest £333,000 since the start of the new financial year. As stated in previous half year reports it is not unusual for the Group to see a significant deteriorating cash flow picture in the first half of the financial year due to the impact of dividend payments, working capital movements and our capital expenditure programmes. The modest deterioration in our cash position to the current half year end bodes well for the full year end position and supports the comment already made on projected debt levels within the Chairman's Statement.

The Group's bank facilities are materially unchanged from those reported within the full year accounts. We would refer you in particular to Note 20.b) on page 53 of those accounts where you can see that our unutilised facilities are significant. Given the profitability of the Group, the modest gearing levels and the bank facilities available to it, the Directors have concluded that drawing up the accounts on a going concern basis is appropriate.

Responsibility statement of the Directors in respect of the half-yearly financial report

The Directors confirm to the best of their knowledge that 1) this condensed set of financial statements has been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union and that 2) the Interim Management Report and condensed financial statements include a fair review of the information required by Disclosure and Transparency Rules 4.2.7R (being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year) and 4.2.8R (being related party transactions that have taken place in the first six months of the financial year and that have materially affected the financial position or performance of the entity during that period; and any changes in the related party transactions described in the last Annual Report that could do so).

 

J. W. Goodwin

 

Chairman

18th December 2017

 

Condensed Consolidated Income Statement

for the half year to 31st October 2017

 

Unaudited

Unaudited

Audited

Half Year to

Half Year to

Year Ended

31st October

31st October

30th April

2017

2016

2017

£'000

£'000

£'000

Continuing operations

Revenue

61,893

69,889

131,587

Cost of sales

(44,758)

(51,442)

(97,836)

Gross profit

17,135

18,447

33,751

Distribution expenses

(1,881)

(1,731)

(3,486)

Administrative expenses

(8,892)

(10,210)

(20,317)

Operating profit

6,362

6,506

9,948

Financial expenses

(419)

(560)

(873)

Share of profit of associate companies

165

101

169

Profit before taxation

6,108

6,047

9,244

Tax on profit

(1,656)

(1,829)

(2,487)

Profit after taxation

4,452

4,218

6,757

Attributable to:

Equity holders of the parent

4,203

3,927

6,082

Non-controlling interests

249

291

675

Profit for the period

4,452

4,218

6,757

Basic and diluted earnings per ordinary share (Note 7)

58.38p

54.53p

84.47p

 

 

Condensed Consolidated Statement of Comprehensive Income

for the half year to 31st October 2017

 

Unaudited

Unaudited

Audited

Half Year to

Half Year to

Year Ended

31st October

31st October

30th April

2017

2016

2017

£'000

£'000

£'000

Profit for the period

4,452

4,218

6,757

Other comprehensive income / (expense)

Items that are or may be reclassified subsequently to the income statement

Foreign exchange translation differences

258

5,796

3,619

Effective portion of changes in fair value of cash flow hedges

(196)

(15,696)

(6,526)

Change in fair value of cash flow hedges transferred to the income statement

932

(608)

2,142

Tax on items that are or may be reclassified subsequently to the income statement

(125)

2,765

738

Other comprehensive income / (expense) for the period, net of income tax

869

(7,743)

(27)

Total comprehensive income / (expense) for the period

5,321

(3,525)

6,730

Attributable to:

Equity holders of the parent

5,151

(4,618)

5,654

Non-controlling interests

170

1,093

1,076

5,321

(3,525)

6,730

 

Condensed Consolidated Statement of Changes in Equity

for the half year to 31st October 2017

Share capital

Translat-ion reserve

Share-based payments reserve

Cash flow hedge reserve

Retained earnings

Total attribut-able to equity holders of the parent

Non-controll-ing interests

Total equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Half year to 31st October, 2017

(Unaudited)

Balance at 1st May, 2017

720

2,154

601

(4,240)

90,201

89,436

4,225

93,661

Total comprehensive income:

Profit

-

-

-

-

4,203

4,203

249

4,452

Other comprehensive income:

Foreign exchange translation differences

-

194

-

-

-

194

64

258

Net movements on cash flow hedges

-

-

-

754

-

754

(143)

611

Total comprehensive income for the period

-

194

-

754

4,203

5,151

170

5,321

Equity-settled share-based payment transactions

-

-

515

-

-

515

-

515

Dividends paid

-

-

-

-

(3,137)

(3,137)

-

(3,137)

Balance at 31st October 2017

720

2,348

1,116

(3,486)

91,267

91,965

4,395

96,360

Half year to 31st October, 2016

(Unaudited)

Balance at 1st May, 2016

720

(1,041)

-

(594)

87,209

86,294

3,823

90,117

Total comprehensive income:

Profit

-

-

-

-

3,927

3,927

291

4,218

Other comprehensive income:

Foreign exchange translation differences

-

4,994

-

-

-

4,994

802

5,796

Net movements on cash flow hedges

-

-

-

(13,539)

-

(13,539)

-

(13,539)

Total comprehensive income for the period

-

4,994

-

(13,539)

3,927

(4,618)

1,093

(3,525)

Dividends paid

-

-

-

-

(3,114)

(3,114)

(339)

(3,453)

Balance at 31st October 2016

720

3,953

-

(14,133)

88,022

78,562

4,577

83,139

 

Share capital

Translat-ion reserve

Share-based payments reserve

Cash flow hedge reserve

Retained earnings

Total attribut-able to equity holders of the parent

Non-controll-ing interests

Total equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Year ended 30th April, 2017

Balance at 1st May, 2016

720

(1,041)

-

(594)

87,209

86,294

3,823

90,117

Total comprehensive income:

Profit

-

-

-

-

6,082

6,082

675

6,757

Other comprehensive income:

Foreign exchange translation differences

-

3,218

-

-

-

3,218

401

3,619

Net movements on cash flow hedges

-

-

-

(3,646)

-

(3,646)

-

(3,646)

Total comprehensive income for the period

-

3,218

-

(3,646)

6,082

5,654

1,076

6,730

Transactions with owners of the Company recognised directly in equity

-

(23)

-

21

(2)

1

(1)

Equity-settled share-based payment transactions

-

-

601

-

-

601

-

601

Dividends paid

-

-

-

-

(3,111)

(3,111)

(675)

(3,786)

Balance at 30th April, 2017

720

2,154

601

(4,240)

90,201

89,436

4,225

93,661

 

 

Condensed Consolidated Balance sheet

as at 31st October 2017

 

 

Unaudited

Unaudited

Audited

 

 

as at

as at

as at

 

 

31st October 2017

31st October 2016

30th April 2017

 

 

£'000

£'000

£'000

Non-current assets

 

 

 

 

Property, plant and equipment

 

66,792

65,207

65,739

Investment in associates

 

2,229

2,032

2,045

Intangible assets

 

18,603

18,584

18,240

 

 

 

 

87,624

85,823

86,024

 

 

Current assets

 

 

 

 

Inventories

 

35,473

43,605

37,657

Trade and other receivables

 

29,688

32,819

26,338

Derivative financial assets

 

556

1,235

1,756

Cash and cash equivalents

 

7,813

5,269

5,172

 

 

 

 

73,530

82,928

70,923

 

 

Total assets

 

161,154

168,751

156,947

 

 

Current liabilities

 

 

 

 

Bank overdrafts

 

9,737

9,347

6,655

Interest-bearing loans and borrowings

 

3,918

3,074

2,887

Trade and other payables

 

21,962

26,647

22,454

Deferred consideration

 

500

500

500

Derivative financial liabilities

 

2,228

13,293

2,492

Liabilities for current tax

 

2,043

2,234

1,592

Warranty provision

 

88

132

90

 

 

 

 

40,476

55,227

36,670

 

 

Non-current liabilities

 

 

 

 

Interest-bearing loans and borrowings

 

21,198

29,571

23,675

Warranty provision

 

337

296

305

Deferred tax liabilities

 

2,783

518

2,636

 

 

 

 

24,318

30,385

26,616

 

 

Total liabilities

 

64,794

85,612

63,286

 

 

Net assets

 

96,360

83,139

93,661

 

 

 

 

 

 

 

Equity attributable to equity holders of the parent

 

 

 

Share capital

 

720

720

720

Translation reserve

 

2,348

3,953

2,154

Share-based payments reserve

 

1,116

-

601

Cash flow hedge reserve

 

(3,486)

(14,133)

(4,240)

Retained earnings

 

91,267

88,022

90,201

 

 

Total equity attributable to equity holders of the parent

91,965

78,562

89,436

Non-controlling interests

 

4,395

4,577

4,225

 

 

Total equity

 

96,360

83,139

93,661

 

 

 

 

Condensed Consolidated Cash Flow Statement

for the half year ended 31st October 2017

 

Unaudited

Unaudited

Audited

 

Half Year to 31st October

Half Year to 31st October

Year ended 30th April

 

2017

2016

2017

 

£'000

£'000

£'000

Cash flow from operating activities

 

 

 

Profit from continuing operations after tax

4,452

4,218

6,757

Adjustments for:

 

 

 

Depreciation

2,644

2,718

5,597

Amortisation of intangible assets

552

393

938

Financial expenses

419

560

873

(Profit)/loss on sale of property, plant and equipment

(1,610)

(2)

52

Share of profit of associate companies

(165)

(101)

(169)

Equity-settled share-based provision

515

-

601

Tax expense

1,656

1,829

2,487

 

Operating profit before changes in working capital and provisions

8,463

9,615

17,136

(Increase) / decrease in trade and other receivables

(3,194)

(2,972)

8,025

Decrease / (increase) in inventories

2,343

(6,167)

(1,014)

Decrease in trade and other payables (excluding payments on account)

(1,020)

(5,732)

(9,445)

Increase / (decrease) in payments on account

3,094

(1,207)

(5,825)

 

Cash inflow / (outflow) from operations

9,686

(6,463)

8,877

Interest paid

(383)

(469)

(802)

Corporation tax paid

(1,254)

(1,460)

(2,675)

Interest element of finance lease obligations

(45)

(91)

(115)

 

Net cash from operating activities

8,004

(8,483)

5,285

 

Cash flow from investing activities

 

 

 

Proceeds from sale of property, plant and equipment

1,811

79

237

Acquisition of intangible assets

(354)

(60)

(149)

Acquisition of property, plant and equipment

(4,850)

(3,218)

(7,411)

R&D expenditure capitalised

(355)

(354)

(791)

 

Net cash outflow from investing activities

(3,748)

(3,553)

(8,114)

 

 

 

 

Cash flows from financing activities

 

 

 

Payment of capital element of finance lease obligations

(429)

(466)

(930)

Dividends paid

(3,137)

(3,114)

(3,111)

Dividends paid to non-controlling interests

-

(339)

(675)

Proceeds from loans and committed facilities

-

11,459

5,871

Repayment of loans and committed facilities

(1,023)

(21)

(44)

 

Net cash (outflow) / inflow from financing activities

(4,589)

7,519

1,111

 

Net decrease in cash and cash equivalents

(333)

(4,517)

(1,718)

Cash and cash equivalents at beginning of year

(1,483)

(413)

(413)

Effect of exchange rate fluctuations on cash held

(108)

852

648

 

Closing cash and cash equivalents

(1,924)

(4,078)

(1,483)

 

 

Notes

to the Condensed Consolidated Financial Statements

1. Reporting entity

Goodwin PLC (the "Company") is a company incorporated in England and Wales. The unaudited condensed consolidated interim financial statements of the Company as at and for the six months ended 31st October 2017 comprise the Company, its subsidiaries, and the Group's interests in associates (together referred to as the "Group").

The audited consolidated financial statements of the Group as at and for the year ended 30th April 2017 are available upon request from the Company's registered office at Ivy House Foundry, Hanley, Stoke-on-Trent ST1 3NR or via the Company's web site: www.goodwin.co.uk.

2. Statement of compliance

These unaudited condensed consolidated interim financial statements have been prepared in accordance with IAS 34 Interim Financial Reporting as adopted in the EU. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the audited consolidated financial statements of the Group as at and for the year ended 30th April 2017.

The comparative figures for the financial year ended 30th April 2017 are extracts and not the full Group's statutory accounts for that financial year. Those accounts have been reported on by the Company's auditors and delivered to the Registrar of Companies. The report of the auditors was (i) unqualified, (ii) did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498(2) or (3) of the Companies Act 2006.

The Audit Committee has reviewed these unaudited condensed consolidated interim financial statements and has advised the Board of Directors that, taken as a whole, they are fair, balanced and understandable and provide the information necessary for shareholders to assess the Group's half year performance. These unaudited condensed consolidated interim financial statements were approved by the Board of Directors on 18th December 2017.

3. Significant accounting policies

The accounting policies applied by the Group in these unaudited condensed consolidated financial statements are the same as those applied by the Group in its audited consolidated financial statements as at and for the year ended 30th April 2017. The following standards and amendments became effective and therefore were adopted by the Group.

• Annual Improvements to IFRSs - 2014-2016 Cycle - minor amendments to IFRS 12 (effective for annual periods beginning on or after 1st January 2017)

• Amendments to IAS 12 - Recognition of Deferred Tax Assets for unrealised losses (effective for annual periods beginning on or after 1st January 2017)

• Amendments to IAS 7 - Disclosure initiative (effective for annual periods beginning on or after 1st January 2017)

The Group has considered the impact of these new standards and interpretations in future periods on profit, earnings per share and net assets. None of the above standards or interpretations is expected to have a material impact.

New IFRS standards, amendments and interpretations not adopted

The IASB and IFRIC have issued additional standards and amendments which are effective for periods starting after the date of these financial statements. The following standards and amendments have not yet been adopted by the Group:

• Annual Improvements to IFRSs - 2014-2016 Cycle - minor amendments to IFRS 1 and IAS 28 (effective for annual periods beginning on or after 1st January 2018)

· Amendments to IFRS 2 - Classification and Measurement of Share-based Payment Transactions (effective for annual periods beginning on or after 1st January 2018)

· Amendments to IFRS 4 - Applying IFRS 9 Financial Instruments with IFRS 4 Insurance Contracts (effective for annual periods beginning on or after 1st January 2018)

• IFRS 9 - Financial Instruments (effective for annual periods beginning on or after 1st January 2018)

• IFRS 15 - Revenue from Contracts with Customers (effective for annual periods beginning on or after 1st January 2018)

• IFRS 15 - Clarifications (effective for annual periods beginning on or after 1st January 2018)

• Amendments to IFRS 40 - Transfers of Investment Property (effective for annual periods beginning on or after 1st January 2018)

• IFRIC Interpretation 22 - Foreign Currency Transactions and Advance Consideration (effective for annual periods beginning on or after 1st January 2018)

• IFRS 16 - Leases (Not yet endorsed. IASB effective date 1st January 2019)

• Amendments to IFRS 2 - Classification and Measurement of Share-based Payment Transactions (not yet endorsed)

4. Estimates

The preparation of interim financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.

In preparing these unaudited consolidated interim financial statements, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those that applied to the audited consolidated financial statements as at and for the year ended 30th April 2017.

The tax charge in the period is based on management's estimate of the weighted average annual income tax rate expected for the full financial year applied to the pre-tax income of the interim period, and the impact of any disallowed costs.

5. Business Segments

Products and services from which reportable segments derive their revenues

In accordance with the requirements of IFRS8 "Operating Segments" the Group's reportable segments based on information reported to the Group's Board of Directors for the purposes of resource allocation and assessment of segment performance are as follows:

• Mechanical Engineering - casting, machining and general engineering

• Refractory Engineering - powder manufacture and mineral processing

Information regarding the Group's operating segments is reported below. 

 

Segment Revenue and Profits

 

Mechanical Engineering

Refractory Engineering

Sub Total

Unaudited Half Year Ended 31st October 2017

Unaudited Half Year Ended 31st October 2016

Audited Year Ended 30th April 2017

Unaudited Half Year Ended 31st October 2017

Unaudited Half Year Ended 31st October 2016

Audited Year Ended 30th April 2017

Unaudited Half Year Ended 31st October 2017

Unaudited Half Year Ended 31st October 2016

Audited Year Ended 30th April 2017

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Revenue

External sales

39,779

50,262

91,335

22,114

19,627

40,252

61,893

69,889

131,587

Inter-segment sales

10,189

13,910

29,084

4,350

2,988

6,522

14,539

16,898

35,606

Total revenue

49,968

64,172

120,419

26,464

22,615

46,774

76,432

86,787

167,193

Reconciliation to consolidated revenues:

Inter-segment sales

(14,539)

(16,898)

(35,606)

Consolidated revenue for the period

61,893

69,889

131,587

Mechanical Engineering

Refractory Engineering

Sub Total

Unaudited Half Year Ended 31st October 2017

Unaudited Half Year Ended 31st October 2016

Audited Year Ended 30th April 2017

Unaudited Half Year Ended 31st October 2017

Unaudited Half Year Ended 31st October 2016

Audited Year Ended 30th April 2017

Unaudited Half Year Ended 31st October 2017

Unaudited Half Year Ended 31st October 2016

Audited Year Ended 30th April 2017

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

 

Profits

Segment result including associates

2,733

4,798

6,982

5,313

2,241

5,933

8,046

7,039

12,915

Group administration costs

(1,004)

(604)

(2,197)

LTIP equity plan provision

(515)

-

(601)

Group finance and treasury costs

(419)

(376)

(873)

Consolidation adjustments

-

(12)

-

Consolidated profit before tax for the period

6,108

6,047

9,244

Tax

(1,656)

(1,829)

(2,487)

Consolidated profit after tax for the period

4,452

4,218

6,757

Segment Assets and Liabilities

 

Segmental total assets

Segmental total liabilities

Segmental net assets

Unaudited Half Year Ended 31st October 2017

Unaudited Half Year Ended 31st October 2016

Audited Year Ended 30th April 2017

Unaudited Half Year Ended 31st October 2017

Unaudited Half Year Ended 31st October 2016

Audited Year Ended 30th April 2017

Unaudited Half Year Ended 31st October 2017

Unaudited Half Year Ended 31st October 2016

Audited Year Ended 30th April 2017

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Mechanical Engineering

85,793

97,284

80,968

66,798

85,210

65,036

18,995

12,074

15,932

Refractory Engineering

45,425

44,635

41,717

24,527

29,285

23,321

20,898

15,350

18,396

Sub total reportable segment

131,218

141,919

122,685

91,325

114,495

88,357

39,893

27,424

34,328

Goodwin PLC (the Company) net assets

68,841

68,467

71,944

Elimination of Goodwin PLC investments

(22,084)

(22,441)

(22,084)

Goodwill

9,710

9,689

9,473

Consolidated total net assets

96,360

83,139

93,661

Segmental property, plant and equipment (PPE) capital expenditure

Goodwin PLC

3,049

2,095

5,070

Mechanical Engineering

687

737

1,611

Refractory Engineering

267

386

918

4,003

3,218

7,599

Geographical Segments

 

Half Year Ended 31st October 2017

Half Year Ended 31st October 2016

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Revenue

Operational assets

Non-current assets

PPE capital expenditure

Revenue

Operational assets

Non-current assets

PPE capital expenditure

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

UK

13,698

63,870

71,656

3,610

11,352

52,149

70,611

2,631

Rest of Europe

14,674

10,483

2,276

136

15,031

10,646

2,480

265

USA

2,544

-

-

-

3,919

-

-

-

Pacific Basin

11,709

14,635

7,505

116

20,615

14,564

5,825

63

Rest of World

19,268

7,372

6,187

141

18,972

5,780

6,907

259

Total

61,893

96,360

87,624

4,003

69,889

83,139

85,823

3,218

Year Ended 30th April 2017

Audited

Audited

Audited

Audited

Revenue

Operational assets

Non-current assets

PPE capital expenditure

£'000

£'000

£'000

£'000

UK

24,034

63,451

69,693

6,504

Rest of Europe

29,712

10,213

2,271

466

USA

6,574

-

-

-

Pacific Basin

33,095

14,012

7,459

210

Rest of World

38,172

5,985

6,601

419

Total

131,587

93,661

86,024

7,599

 

 

6. Dividends

The Directors do not propose the payment of an interim dividend.

 

 

 

Unaudited

Unaudited

Audited

 

 

Half Year to

Half Year to

Year Ended

 

 

31st October 2017

31st October 2016

30th April 2017

 

 

£'000

£'000

£'000

Equity Dividends Paid:

 

 

 

 

Ordinary dividends paid during the period in respect of the year ended 30th April 2017 (42.348p per share)

 

3,049

-

-

Ordinary dividends paid during the period in respect of the year ended 30th April 2016 (42.348p per share)

 

-

3,049

3,049

Dividends paid to minority shareholders in Noreva GmbH

 

88

65

62

 

 

Total dividends paid during the period

 

3,137

3,114

3,111

 

 

 

7. Earnings Per Share

The calculation of the basic earnings per ordinary share is based on the number of ordinary shares in issue during all periods of 7,200,000, and on the profit for the six months attributable to ordinary shareholders of £4,203,000 (six months to 31st October 2016: £3,927,000).

 

8. Capital Management, Issuance and Repayment of Debt

At 31st October 2017 the capital utilised was £119,505,000 as shown below:

 

 

 

Unaudited

Unaudited

Audited

 

 

as at

as at

as at

 

 

31st October 2017

31st October 2016

30th April 2017

 

 

£'000

£'000

£'000

 

 

 

 

 

Cash and cash equivalents

 

(7,813)

(5,269)

(5,172)

Finance leases

 

2,984

3,878

3,413

Bank loans and committed facilities

 

22,132

28,767

23,149

Bank overdrafts

 

9,737

9,347

6,655

Deferred consideration

 

500

500

500

 

 

Net debt

 

27,540

37,223

28,545

Total equity attributable to equity holders of the parent

 

91,965

78,562

89,436

 

 

Capital

 

119,505

115,785

117,981

 

 

 

9. Property, Plant and Equipment

 

 

 

Unaudited

Unaudited

 

 

as at

as at

 

 

31st October 2017

31st October 2016

 

 

£'000

£'000

 

 

 

 

Net book value at the beginning of the period

 

65,739

62,530

Additions

 

4,003

3,218

Disposals (at net book value)

 

(201)

(77)

Depreciation

 

(2,644)

(2,718)

Exchange adjustment

 

(105)

2,254

 

 

Net book value at the end of the period

 

66,792

65,207

 

 

 

10. Intangible assets

 

 

 

Unaudited

Unaudited

 

 

as at

as at

 

 

31st October 2017

31st October 2016

 

 

£'000

£'000

 

 

 

 

Net book value at the beginning of the period

 

18,240

17,565

Additions

 

709

484

Amortisation

 

(552)

(393)

Exchange adjustment

 

206

928

 

 

Net book value at the end of the period

 

18,603

18,584

 

 

 

11. Hedge reserve

The Group is exposed to sales and purchases in foreign currency and, in order to mitigate the foreign exchange risk, the Group at its discretion uses hedges where deemed appropriate by the Board. The majority of the Group's hedging activity is in relation to UK company sales contracts in US Dollars and Euros.

 

12. Total Financial Assets and Financial Liabilities

The table below sets out the Group's accounting classification of its financial assets and financial liabilities, and their carrying values / fair values at 31st October 2017. The fair values of all financial assets and financial liabilities are not materially different to the carrying values.

 

 

 

 

Carrying value / Fair value

 

 

 

£'000

Financial assets

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

7,813

Receivables

 

 

 

Trade receivables

 

 

23,847

Other receivables

 

 

5,841

At fair value through the income statement

 

Derivative financial assets not designated in a cash flow hedge relationship

 

535

Designated cash flow hedge relationships

 

Derivative financial assets designated and effective as cash flow hedging instruments

 

21

 

 

Total financial assets

 

 

38,057

 

 

Financial liabilities

 

 

 

 

 

 

 

Financial liabilities at amortised cost

 

 

 

Bank overdraft

 

 

9,737

Trade payables

 

 

9,199

Other payables

 

 

12,763

Deferred consideration

 

 

500

Finance lease liabilities

 

 

2,984

Bank loans

 

 

22,132

Corporation tax

 

 

2,043

At fair value through the income statement

 

 

Derivative financial liabilities not designated in a cash flow hedge relationship

 

32

Designated cash flow hedge relationships

 

 

Derivative financial liabilities designated and effective as cash flow hedging instruments

 

2,196

 

 

Total financial liabilities

 

 

61,586

 

 

 

Derivative financial assets and financial liabilities fair values in the above table are derived using Level 2 inputs as defined by IFRS 7 as detailed in the paragraph below*. All other financial assets and financial liabilities fair values are determined using Level 3 inputs.

*IFRS 7 requires that the classification of financial instruments at fair value be determined by reference to the source of inputs used to derive the fair value. This classification uses the following three-level hierarchy:

Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2 - inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices);

Level 3 - inputs for the asset or liability that are not based on observable market data (unobservable inputs).

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DMMMZGRNGNZM
Date   Source Headline
15th Apr 20243:02 pmRNSDirector/PDMR Shareholding
28th Mar 20242:12 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSMarch 2024 Trading Update
20th Dec 20237:00 amRNSHalf-year Report
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20233:12 pmRNSDirector/PDMR Shareholding
29th Aug 20234:02 pmRNSPosting of Annual Report and Accounts
8th Aug 20237:00 amRNSPreliminary results for the year ended 30 Apr 2023
30th Jun 20237:00 amRNSTotal Voting Rights
5th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSResult of Tender Offer, TVR & Directors' interests
30th May 20232:39 pmRNSResult of General Meeting
5th May 20231:05 pmRNSProposed Tender Offer
3rd Apr 20237:00 amRNSDirector Retirement
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
22nd Dec 202210:34 amRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSHalf-year Report
22nd Nov 20224:35 pmRNSPrice Monitoring Extension
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20222:54 pmRNSResult of AGM
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
19th Aug 20222:38 pmRNSPosting of Annual Report and Accounts
3rd Aug 20227:00 amRNSFinal Results
6th Apr 202212:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSHalf-year Report
18th Oct 20214:07 pmRNSDirector/PDMR Shareholding
15th Oct 20214:40 pmRNSSecond Price Monitoring Extn
15th Oct 20214:35 pmRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSDirector/PDMR Shareholding
6th Oct 20212:38 pmRNSResult of AGM
31st Aug 20217:00 amRNSPosting of Annual Report and Accounts
26th Aug 202110:25 amRNSDeath of an Employee
11th Aug 20217:00 amRNSFinal Results
1st Jun 20217:00 amRNSIssue of Equity and Director/PDMR Shareholding
13th May 20214:41 pmRNSSecond Price Monitoring Extn
13th May 20214:36 pmRNSPrice Monitoring Extension
11th May 20214:41 pmRNSSecond Price Monitoring Extn
11th May 20214:36 pmRNSPrice Monitoring Extension
30th Apr 20214:35 pmRNSPrice Monitoring Extension
23rd Apr 20212:52 pmRNSDirector/PDMR Shareholding
8th Apr 20214:40 pmRNSSecond Price Monitoring Extn
8th Apr 20214:36 pmRNSPrice Monitoring Extension
6th Apr 20214:42 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
8th Mar 202111:18 amRNSDirector/PDMR Shareholding
16th Dec 20207:00 amRNSHalf-year Report
11th Dec 20201:53 pmRNSDirectorate Change
5th Nov 202011:46 amRNSDirector/PDMR Shareholding
30th Oct 20207:00 amRNSIssue of Equity and Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.